Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
30 hedge funds and large institutions have $3.33M invested in Repros Therapeutics Inc. in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.
94% more capital invested
Capital invested by funds: $1.72M → $3.33M (+$1.61M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
7% more funds holding
Funds holding: 28 → 30 (+2)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Kassirer Asset Management
Toronto,
Ontario, Canada
|
+$333K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.4K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$12.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.83K |
| 5 |
Bank of New York Mellon
New York
|
+$7.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$165K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$159K |
| 3 |
GAI
General American Investors
New York
|
-$76K |
| 4 |
VF
Virtu Financial
New York
|
-$42K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OIA
26
OneDigital Investment Advisors
Overland Park,
Kansas
| – | -$5K | -16,400 | Closed |
|
|
TSS
27
Two Sigma Securities
New York
| – | -$4K | -10,962 | Closed |
|
28
Morgan Stanley
New York
| – | -$995 | -1,972 | -83% |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$126 | +250 | +167% |
|
|
HFP
30
Holistic Financial Partners
Indianapolis,
Indiana
| – | +$325 | +643 | New |
|
RPRX Hedge Fund Activity: Q4 2017 in Review
30 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q4 2017, worth a combined $3.33M — up 94% from $1.72M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RPRX positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Kassirer Asset Management, opening a new position worth an estimated $333K. The largest seller was Renaissance Technologies, cutting an estimated $165K.
- 30 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q4 2017, up from 28 in Q3 2017.
- Funds reported $3.33M of Repros Therapeutics Inc. stock for Q4 2017, up 94% quarter-over-quarter.
- 6 funds opened new Repros Therapeutics Inc. positions in Q4 2017 and 4 closed out, a net change of +2 holders.
- The largest Repros Therapeutics Inc. buyer in Q4 2017 was Kassirer Asset Management, an estimated $333K added.
- The largest Repros Therapeutics Inc. seller in Q4 2017 was Renaissance Technologies, an estimated $165K sold.
Based on aggregated 13F filings for Q4 2017.